LANSTOPACID is an inhibitor of the acid-production enzymatic system. It acts by decreasing hyperacidity and its related symptoms (pyrosis, epigastric or thoracic pain).
Treatment and maintenance in esophagitis caused by gastroesophageal reflux.
Acute treatment of duodenal ulcer, gastric ulcer, and esophagitis caused by gastroesophageal reflux.
Eradication of Helicobacter pylori in patients with benign duodenal ulcer, and gastric ulcer, in combination with suitable antibiotics.
Effective in chronic treatment of Barrett esophagus in the Zollinger-Ellison syndrome.
As prescribed by physician
Presentation: Box With 3 Strip Packs, 10 Capsules Each